DMCC Speciality Chemicals Limited (BOM:506405)

Market Cap	7.45B
Revenue (ttm)	4.73B
Net Income (ttm)	279.13M
Shares Out	24.94M
EPS (ttm)	11.19
PE Ratio	26.71
Forward PE	n/a
Dividend	2.50 (0.84%)
Ex-Dividend Date	Aug 28, 2024

Volume	2,107
Average Volume	19,515
Open	309.60
Previous Close	313.00
Day's Range	301.65 - 313.00
52-Week Range	241.35 - 452.00
Beta	0.18
RSI	52.08
Earnings Date	Aug 8, 2025

About Regulus Therapeutics

DMCC Speciality Chemicals Limited manufactures and sells specialty and commodity chemicals in India and internationally. The company offers base, boron, functional, and life science chemicals. Its products are used in various applications in textile processing, emulsions, polymers, dyes and pigments, pharmaceuticals intermediates, electroplating, thermal paper coating, fire retardants, agro-chemicals, water treatment, fertilizers, cosmetics, construction chemicals, detergent, ink, and paper. The company was formerly known as The Dharamsi Morarj...

• Industry: Chemicals and Allied Products
• Founded: 1919
• Employees: 418
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506405

Financial Performance

In 2024, DMCC Speciality Chemicals's revenue was 4.31 billion, an increase of 31.51% compared to the previous year's 3.28 billion. Earnings were 215.28 million, an increase of 85.76%.